Pro Dex (PDEX) Cash from Financing Activities (2010 - 2026)
Pro Dex (PDEX) posted Cash from Financing Activities of $5.5 million for Q1 2026, up 209.22% sequentially from -$5.0 million in Q4 2025, and up 183.59% YoY from $1.9 million in Q1 2025.
Pro Dex (PDEX) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Pro Dex has reported Cash from Financing Activities for 15 years, with the latest figure at $5.5 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 183.59% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.5 million (down 524.37% YoY) and the FY2025 annual result came in at -$292000.0, up 93.2% from the prior year.
- Cash from Financing Activities improved to $5.5 million in Q1 2026 per PDEX's latest filing, from -$5.0 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $5.5 million in Q1 2026 and troughed at -$5.0 million in Q4 2025.
- A 5-year average of -$486235.3 and a median of -$853000.0 in 2022 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 200.54% in 2024, down 509.12% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$1.5 million in 2022, then soared by 136.88% to $558000.0 in 2023, then jumped by 200.54% to $1.7 million in 2024, then slumped by 398.21% to -$5.0 million in 2025, then surged by 209.22% to $5.5 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $5.5 million, -$5.0 million, and -$2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Pro Dex | 209.47 Mn | 198.49 Mn | 6.13 Mn | 5.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.46 Mn |
| Mar 31, 2026 | 5.46 Mn |
| Dec 31, 2025 | -5.00 Mn |
| Dec 31, 2025 | -5.00 Mn |
| Sep 30, 2025 | -2.12 Mn |
| Sep 30, 2025 | -2.12 Mn |
| Jun 30, 2025 | -2.89 Mn |
| Jun 30, 2025 | -2.89 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | -1.01 Mn |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | -1.53 Mn |
| Jun 30, 2024 | -1.53 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Dec 31, 2023 | 558,000.00 |
| Dec 31, 2023 | 558,000.00 |